- Filed
- Jan 13, 2023 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2023 · Jan 13, 2023 | 107.48M sh |
| Cash And Equivalents | Q2 2023 · Nov 30, 2022 | $1.01M |
| Cash And Equivalents | Q2 2023 · May 31, 2022 | $1.14M |
| Current Liabilities | Q2 2023 · Nov 30, 2022 | $2.79M |
| Current Liabilities | Q2 2023 · May 31, 2022 | $2.62M |
| Total Liabilities | Q2 2023 · Nov 30, 2022 | $13.29M |
| Total Liabilities | Q2 2023 · May 31, 2022 | $13.12M |
| Current Assets | Q2 2023 · Nov 30, 2022 | $1.01M |
| Current Assets | Q2 2023 · May 31, 2022 | $1.14M |
| Total Assets | Q2 2023 · Nov 30, 2022 | $1.06M |
| Total Assets | Q2 2023 · May 31, 2022 | $1.27M |
| Rd Expense | Q2 2023 · May 31, 2022 | $1.62M |
| Rd Expense | Q2 2023 · Nov 30, 2021 | $505.5K |
| Rd Expense | Q2 2023 · Nov 30, 2021 | $1.01M |
| Rd Expense | Q2 2023 · May 31, 2021 | $842.5K |
| Shares Diluted | Q2 2023 · Nov 30, 2021 | 107.48M sh |
| Shares Diluted | Q2 2023 · Nov 30, 2021 | 107.48M sh |
| Operating Cash Flow | Q2 2023 · Nov 30, 2021 | −$1.14M |
| Stockholders Equity | Q2 2023 · Nov 30, 2021 | −$10.86M |
| Stockholders Equity | Q2 2023 · Aug 31, 2021 | −$10.17M |
| Stockholders Equity | Q2 2023 · May 31, 2021 | −$9.46M |
| Eps Diluted | Q2 2023 · Nov 30, 2021 | −$0.01 |
| Eps Diluted | Q2 2023 · Nov 30, 2021 | −$0.01 |
| Eps Basic | Q2 2023 · Nov 30, 2021 | −$0.01 |
| Eps Basic | Q2 2023 · Nov 30, 2021 | −$0.01 |
| Net Income | Q2 2023 · Nov 30, 2021 | −$689.73K |
| Net Income | Q2 2023 · Nov 30, 2021 | −$1.4M |
| Operating Income | Q2 2023 · Nov 30, 2021 | −$561K |
| Operating Income | Q2 2023 · Nov 30, 2021 | −$1.14M |